Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study.
Bouchi R, Terashima M, Sasahara Y, Asakawa M, Fukuda T, Takeuchi T, Nakano Y, Murakami M, Minami I, Izumiyama H, Hashimoto K, Yoshimoto T, Ogawa Y.
Bouchi R, et al.
Cardiovasc Diabetol. 2017 Mar 3;16(1):32. doi: 10.1186/s12933-017-0516-8.
Cardiovasc Diabetol. 2017.
PMID: 28253918
Free PMC article.
Clinical Trial.